Immatics NV (IMTX)
8.69
-0.24
(-2.69%)
USD |
NASDAQ |
Aug 24, 16:00
8.70
+0.01
(+0.12%)
After-Hours: 20:00
Immatics Price to Book Value : 2.600 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 2.600 |
| August 21, 2026 | 2.672 |
| August 20, 2026 | 2.558 |
| August 19, 2026 | 2.767 |
| August 18, 2026 | 2.720 |
| August 17, 2026 | 2.767 |
| August 14, 2026 | 2.824 |
| August 13, 2026 | 2.869 |
| August 12, 2026 | 2.905 |
| August 11, 2026 | 2.917 |
| August 10, 2026 | 2.908 |
| August 07, 2026 | 2.887 |
| August 06, 2026 | 2.818 |
| August 05, 2026 | 2.923 |
| August 04, 2026 | 2.806 |
| August 03, 2026 | 2.698 |
| July 31, 2026 | 2.591 |
| July 30, 2026 | 2.752 |
| July 29, 2026 | 2.690 |
| July 28, 2026 | 2.613 |
| July 27, 2026 | 2.582 |
| July 24, 2026 | 2.716 |
| July 23, 2026 | 2.779 |
| July 22, 2026 | 2.743 |
| July 21, 2026 | 2.815 |
| Date | Value |
|---|---|
| July 20, 2026 | 2.761 |
| July 17, 2026 | 2.869 |
| July 16, 2026 | 2.812 |
| July 15, 2026 | 2.833 |
| July 14, 2026 | 2.797 |
| July 13, 2026 | 2.761 |
| July 10, 2026 | 2.896 |
| July 09, 2026 | 2.980 |
| July 08, 2026 | 2.986 |
| July 07, 2026 | 3.070 |
| July 06, 2026 | 2.989 |
| July 02, 2026 | 2.977 |
| July 01, 2026 | 2.947 |
| June 30, 2026 | 3.031 |
| June 29, 2026 | 2.488 |
| June 26, 2026 | 2.478 |
| June 25, 2026 | 2.479 |
| June 24, 2026 | 2.608 |
| June 23, 2026 | 2.579 |
| June 22, 2026 | 2.545 |
| June 18, 2026 | 2.545 |
| June 17, 2026 | 2.478 |
| June 16, 2026 | 2.366 |
| June 15, 2026 | 2.454 |
| June 12, 2026 | 2.441 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| MediGene AG | -- |
| InflaRx NV | 1.808 |
| BioNTech SE | 1.396 |
| Moderna, Inc. | 8.197 |
| Intellia Therapeutics, Inc. | 2.417 |
Price to Book Value Related Metrics
| PS Ratio | 23.20 |
| PEG Ratio | -0.0263 |
| Price | 8.69 |
| Earnings Yield | -21.28% |
| Market Cap | 1.188B |
| PEGY Ratio | -0.0263 |